Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
UBS
Cantor Fitzgerald
US Department of Justice
McKesson
AstraZeneca
Argus Health
Covington
QuintilesIMS

Generated: January 16, 2019

DrugPatentWatch Database Preview

PIPERACILLIN SODIUM; TAZOBACTAM SODIUM - Generic Drug Details

« Back to Dashboard

What are the generic sources for piperacillin sodium; tazobactam sodium and what is the scope of piperacillin sodium; tazobactam sodium freedom to operate?

Piperacillin sodium; tazobactam sodium is the generic ingredient in three branded drugs marketed by Apollo Pharms Inc, Aurobindo Pharma Ltd, Fresenius Kabi, Fresenius Kabi Usa, Hospira Inc, Istituto Bio Ita Spa, Mylan Labs Ltd, Qilu Tianhe, Sandoz, Sandoz Inc, Wockhardt Bio Ag, and Wyeth Pharms, and is included in nineteen NDAs. There are four patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Piperacillin sodium; tazobactam sodium has fifty-four patent family members in thirty-three countries.

There are sixteen drug master file entries for piperacillin sodium; tazobactam sodium. Fifteen suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for PIPERACILLIN SODIUM; TAZOBACTAM SODIUM
International Patents:54
US Patents:4
Tradenames:3
Applicants:12
NDAs:19
Drug Master File Entries: 16
Suppliers / Packagers: 15
Clinical Trials: 4
DailyMed Link:PIPERACILLIN SODIUM; TAZOBACTAM SODIUM at DailyMed
Pharmacology for PIPERACILLIN SODIUM; TAZOBACTAM SODIUM
Tentative approvals for PIPERACILLIN SODIUM; TAZOBACTAM SODIUM
Applicant Application No. Strength Dosage Form
➤ Sign Up➤ Sign UpEQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIALINJECTABLE;INJECTION
➤ Sign Up➤ Sign Up13.5G/VIALINJECTABLE;INJECTION

US Patents and Regulatory Information for PIPERACILLIN SODIUM; TAZOBACTAM SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Pharms ZOSYN IN PLASTIC CONTAINER piperacillin sodium; tazobactam sodium INJECTABLE;INJECTION 050750-002 Feb 24, 1998 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Aurobindo Pharma Ltd PIPERACILLIN AND TAZOBACTAM piperacillin sodium; tazobactam sodium INJECTABLE;INJECTION 065498-002 May 23, 2011 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira Inc PIPERACILLIN AND TAZOBACTAM piperacillin sodium; tazobactam sodium INJECTABLE;INJECTION 065386-003 Sep 15, 2009 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
AstraZeneca
QuintilesIMS
Deloitte
Medtronic
Accenture
Covington
Cipla
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.